Treatment for LTBI in contacts of MDR-TB patients, Federated States of Micronesia, 2009-2012.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  The International Journal of Tuberculosis and Lung Disease

• Publication date

  2014-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.5588/ijtld.13.0028PMID 25199004PMCID PMC4730114
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination

  2013cited by this paper
• Lack of evidence to support policy development for management of contacts of multidrug-resistant tuberculosis patients: two systematic reviews.

  2012cited by this paper
• Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes

  2012cited by this paper
• Tuberculosis in household contacts of multidrug-resistant tuberculosis patients.

  2011cited by this paper
• Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting.

  2011cited by this paper
• Islands of hope: building local capacity to manage an outbreak of multidrug-resistant tuberculosis in the Pacific.

  2011cited by this paper
• Global policies and practices for managing persons exposed to multidrug-resistant tuberculosis.

  2010cited by this paper
• Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis.

  2010cited by this paper
• Treatment Outcomes of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis

  2009cited by this paper
• Two simultaneous outbreaks of multidrug-resistant tuberculosis--Federated States of Micronesia, 2007-2009.

  2009cited by this paper
• Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis.

  2009cited by this paper
• Comparative Safety Profile of Levofloxacin in 2523 Children With a Focus on Four Specific Musculoskeletal Disorders

  2007cited by this paper
• Multidrug-resistant Tuberculosis in Military Recruits

  2006cited by this paper
• Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa.

  2006cited by this paper
• Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America.

  2005cited by this paper
• Treatment completion and costs of a randomized trial of rifampin for 4 months versus isoniazid for 9 months.

  2004cited by this paper
• Current medical treatment for tuberculosis

  2002cited by this paper
• Pulmonary Tuberculosis : A 30-Month Follow-up Evaluation of Young Children in Contact With Adult Multidrug-Resistant

  2002cited by this paper
• Multidrug-resistant tuberculosis.

  2002cited by this paper
• Molecular epidemiology of tuberculosis in the Netherlands: a nationwide study from 1993 through 1997.

  1999cited by this paper
• Asymptomatic hepatitis in persons who received alternative preventive therapy with pyrazinamide and ofloxacin.

  1997cited by this paper
• Outbreak of drug-resistant tuberculosis with second-generation transmission in a high school in California.

  1997cited by this paper
• Positive PPD and chemoprophylaxis for tuberculosis infection.

  1995cited by this paper
• Positive PPD and chemoprophylaxis for tuberculosis infection.

  1995cited by this paper
• Limited tolerance of ofloxacin and pyrazinamide prophylaxis against tuberculosis.

  1994cited by this paper
• Preventive therapy for contacts of multidrug-resistant tuberculosis. A Delphi survey.

  1994cited by this paper
• Treatment of multidrug-resistant tuberculosis.

  1993cited by this paper
• Treatment of multidrug-resistant tuberculosis

  1993cited by this paper

• Safety, efficacy and feasibility of preventive treatment for drug-resistant tuberculosis with moxifloxacin or bedaquiline

  2025cites this paper
• Clinical practice guideline for the evaluation, treatment, and follow-up of children in contact with patients with pulmonary tuberculosis in Colombia

  2025cites this paper
• Lower Tuberculosis Incidence Among People With Human Immunodeficiency Virus Who Completed Isoniazid Preventive Therapy in Ukraine, a High-Burden Multidrug-Resistant Tuberculosis Setting: A Retrospective Cohort Study.

  2025cites this paper
• Update on MDR-TB preventive therapy towards the global TB elimination.

  2025cites this paper
• Adherence to treatment for tuberculosis infection in children using a comprehensive care strategy: a prospective cohort study with a historical control group

  2025cites this paper
• Management of individuals exposed to multidrug-resistant or rifampicin-resistant tuberculosis.

  2025cites this paper
• Operational considerations of select new treatment recommendations for drug-susceptible and drug-resistant tuberculosis

  2025cites this paper
• Prevalence of tuberculosis infection among contacts of drug-resistant tuberculosis patients: A systematic review and meta-analysis.

  2024cites this paper
• Management of Newborns and Healthcare Workers Exposed to Isoniazid-Resistant Congenital Tuberculosis in the Neonatal Intensive Care Unit.

  2024cites this paper
• Acceptability of levofloxacin dispersible and non-dispersible tablet formulations in children receiving TB preventive treatment

  2024cites this paper
• Impacts of MDR/XDR-TB on the global tuberculosis epidemic: Challenges and opportunities

  2024cites this paper
• Diagnosis and Treatment of Latent Tuberculosis Infection in Adults in South Korea

  2024cites this paper
• Chapitre 6: Le traitement préventif de la tuberculose chez les adultes

  2023cites this paper
• Fluoroquinolone-resistant latent tuberculosis infection: A literature review and case series of 5 patients treated with linezolid monotherapy

  2023cites this paper
• Effectiveness and safety of tuberculosis preventive treatment for contacts of multidrug-resistant tuberculosis patients: A systematic review and Meta-analysis.

  2023cites this paper
• Contact screening and management in a high-transmission MDR-TB setting in Papua New Guinea: Progress, challenges and future directions

  2023cites this paper
• Challenges and the Way forward in Diagnosis and Treatment of Tuberculosis Infection

  2023cites this paper
• Safety of new tuberculosis treatment regimens and compliance with these regimens according to data from the Republic of Kazakhstan

  2023cites this paper
• Prioritizing persons deprived of liberty in global guidelines for tuberculosis preventive treatment

  2023cites this paper
• Challenges in the screening and treatment of latent multidrug-resistant tuberculosis infection.

  2022cites this paper
• Chapter 6: Tuberculosis preventive treatment in adults

  2022cites this paper
• Increasing tuberculosis preventive treatment (TPT) uptake in children

  2022cites this paper
• Tuberculosis in Children.

  2022cites this paper
• Clinical standards for the diagnosis, treatment and prevention of TB infection

  2022cites this paper
• Preventive Therapy for Contacts of Drug-Resistant Tuberculosis

  2022cites this paper
• Caregiver willingness to give TPT to children living with drug-resistant TB patients

  2022cites this paper
• A multidrug-resistant tuberculosis outbreak among immigrants in Tokyo, Japan, 2019-2021.

  2022cites this paper
• Testing and Scaling Interventions to Improve the Tuberculosis Infection Care Cascade.

  2022cites this paper
• Safety of Antimicrobials for Postexposure Prophylaxis and Treatment of Anthrax: A Review.

  2022cites this paper
• A scoping review of paediatric latent tuberculosis infection care cascades: initial steps are lacking

  2021cites this paper
• Management of childhood and adolescent latent tuberculous infection (LTBI) in Germany, Austria and Switzerland

  2021cites this paper
• Effectiveness of Preventive Therapy for Persons Exposed at Home to Drug-Resistant Tuberculosis, Karachi, Pakistan

  2021cites this paper
• Levofloxacin versus placebo for the treatment of latent tuberculosis among contacts of patients with multidrug-resistant tuberculosis (the VQUIN MDR trial): a protocol for a randomised controlled trial

  2020cites this paper
• TB Preventive Therapy for individuals exposed to drug-resistant tuberculosis: feasibility and safety of a community-based delivery of fluoroquinolone-containing preventive regimen.

  2020cites this paper
• Missed opportunities in tb clinical practice: How to bend the curve? A medical, social, economic and ethical point of view.

  2020cites this paper
• The paradigm shift in the approach to management of latent tuberculosis infection in high tuberculosis burden countries

  2020cites this paper
• The Growing Importance of Tuberculosis Preventive Therapy and How Research and Innovation Can Enhance Its Implementation on the Ground

  2020cites this paper
• Risk factors for adverse events in household contacts prescribed preventive treatment for drug-resistant TB exposure.

  2020cites this paper
• MDR/XDR-TB management of patients and contacts: challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network.

  2020cites this paper
• Превентивная химиотерапия у детей из очагов туберкулеза с множественной лекарственной устойчивостью возбудителя

  2019cites this paper
• The emergency response to multidrug-resistant tuberculosis in Daru, Western Province, Papua New Guinea, 2014-2017.

  2019cites this paper
• Willingness to Take Multidrug-Resistant Tuberculosis (MDR-TB) Preventive Therapy among Adult and Adolescent Household Contacts of MDR-TB Index Cases: An International Multi-Site Cross-Sectional Study.

  2019cites this paper
• Newer Drugs for Tuberculosis Prevention and Treatment in Children

  2019cites this paper
• Treatment of Drug-Resistant Tuberculosis.

  2019cites this paper
• The Global Landscape of Tuberculosis Therapeutics.

  2019cites this paper
• Pharmacokinetics of Levofloxacin in Children Treated for Exposure to Drug-Resistant Tuberculosis

  2019cites this paper
• Exposed! Management of MDR-TB household contacts in an evidence light era.

  2019cites this paper
• Treatment for latent tuberculosis infection in low- and middle-income countries: progress and challenges with implementation and scale-up

  2019cites this paper
• Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline

  2019cites this paper
• Treatment of Latent Tuberculosis Infection-An Update.

  2019cites this paper
• Antimycobacterial Consideration in Transplantation Including Drug Non-susceptibility and Resistance: Tuberculosis and Nontuberculous Mycobacterial Disease

  2019cites this paper
• Fluoroquinolones for the treatment of latent Mycobacterium tuberculosis infection in liver transplantation

  2019cites this paper
• Multidrug-resistant tuberculosis infection and disease in children: a review of new and repurposed drugs

  2019cites this paper
• Treatment of Multidrug-Resistant Tuberculosis Infection in Children

  2018cites this paper
• Better than a pound of cure: preventing the development of multidrug-resistant tuberculosis.

  2018cites this paper
• Treatment of Multidrug-resistant Tuberculosis Infection in Children

  2018cites this paper
• Diagnosis and therapeutic approach of latent tuberculosis infection.

  2018cites this paper
• Surprising pathological and clinical manifestations of miliary tuberculosis

  2018cites this paper
• Is Chemoprophylaxis for Child Contacts of Drug-Resistant TB Patients Beneficial? A Systematic Review

  2018cites this paper
• Updates in the Treatment of Active and Latent Tuberculosis

  2018cites this paper
• Prevention and Management of Tuberculosis in Solid Organ Transplant Recipients.

  2018cites this paper
• Tuberculosis preventive treatment: the next chapter of tuberculosis elimination in India

  2018cites this paper
• Addressing critical knowledge gaps to improve and shorten multidrug-resistant tuberculosis treatment regimens in children

  2018cites this paper
• Design of novel F-ATP synthase inhibitors of mycobacterium tuberculosis

  2018cites this paper
• Isoniazid Preventative Therapy uptake for child household contacts of tuberculosis index cases, Kisumu County, Kenya, 2014-2015

  2018cites this paper
• Management of Tuberculosis in Special Populations

  2017cites this paper
• S2k-Leitlinie zur Diagnostik, Prävention und Therapie der Tuberkulose im Kindes- und Jugendalter

  2017cites this paper
• Levofloxacin Population Pharmacokinetics in South African Children Treated for Multidrug-Resistant Tuberculosis

  2017cites this paper
• The management of infection with Mycobacterium tuberculosis in young children post-2015: an opportunity to close the policy-practice gap

  2017cites this paper
• Preventing the spread of multidrug-resistant tuberculosis and protecting contacts of infectious cases.

  2017cites this paper
• Drug-Resistant tuberculosis - primary transmission and management.

  2017cites this paper
• Clinical management of adults and children with multidrug-resistant and extensively drug-resistant tuberculosis.

  2017cites this paper
• Preventive therapy for latent tuberculosis infection-the promise and the challenges.

  2017cites this paper
• Is IPT more effective in high-burden settings? Modelling the effect of tuberculosis incidence on IPT impact

  2017cites this paper
• Diagnosis and therapeutic approach of latent tuberculosis infection.

  2017cites this paper
• Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis

  2017cites this paper
• [Consensus-Based Guidelines for Diagnosis, Prevention and Treatment of Tuberculosis in Children and Adolescents - A Guideline on Behalf of the German Society for Pediatric Infectious Diseases (DGPI)].

  2017cites this paper
• The tuberculosis taboo.

  2017cites this paper
• Overcoming challenges in the diagnosis, prevention, and treatment of pediatric drug-resistant tuberculosis

  2017cites this paper
• Optimizing the management of children with latent tuberculosis infection

  2017cites this paper
• The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis.

  2017cites this paper
• Treatment of Tuberculosis Infection in Children

  2017cites this paper
• Diagnosis and management of latent tuberculosis

  2016cites this paper
• Outbreak of multidrug-resistant tuberculosis in two secondary schools.

  2016cites this paper
• Prospective Study of Moxifloxacin prophylaxis in Patients Suffering with HIV Having Contact History of Multidrug Resistant Tuberculosis (MDR-TB)

  2016cites this paper
• Multidrug-Resistant Tuberculosis in Children: Recent Developments in Diagnosis, Treatment and Prevention

  2016cites this paper
• Outbreak of multidrug-resistant tuberculosis in two secondary schools.

  2016cites this paper
• Fluoroquinolones for the treatment and prevention of multidrug-resistant tuberculosis.

  2016cites this paper
• Pharmacokinetics and Dosing of Levofloxacin in Children Treated for Active or Latent Multidrug-resistant Tuberculosis, Federated States of Micronesia and Republic of the Marshall Islands

  2016cites this paper
• Managing tuberculosis infection in children in the USA: an update.

  2016cites this paper
• Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda

  2016cites this paper
• The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis.

  2016cites this paper
• Updates on the risk factors for latent tuberculosis reactivation and their managements

  2016cites this paper
• Fluoroquinolone Therapy for the Prevention of Multidrug-Resistant Tuberculosis in Contacts. A Cost-Effectiveness Analysis.

  2015cites this paper
• A bitter pill to swallow: the need for better medications for drug-resistant tuberculosis in children.

  2015cites this paper
• Tuberculosis Prophylaxis With Levo fl oxacin in Liver Transplant Patients Is Associated With a High Incidence of Tenosynovitis : Safety Analysis of a Multicenter Randomized Trial

  2015cites this paper
• Unmasking childhood tuberculosis in Pakistan: efforts to improve detection and management.

  2015cites this paper
• Recent Developments and Future Opportunities in the Treatment of Tuberculosis in Children.

  2015cites this paper
• Moxifloxacin Prophylaxis against MDR TB, New York, New York, USA

  2015cites this paper
• Pharmacokinetics and Safety of Moxi fl oxacin in Children With Multidrug-Resistant Tuberculosis

  2015cites this paper